Trials / Terminated
TerminatedNCT02051764
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
An Open Label, Multicenter Study, Evaluating the Imaging Characteristics of a Follow-up 18F-AV-1451 Scan in Subjects Who Have Had a Prior 18F-AV-1451 Scan
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the imaging characteristics of flortaucipir in subjects with a previous flortaucipir scan in order to assess the rate of change of tau deposition over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flortaucipir F18 | 370 megabecquerel (MBq) IV single-dose |
| DRUG | Florbetapir F 18 | 370 megabecquerel (MBq) IV single-dose |
| PROCEDURE | Brain PET Scan | positron emission tomography (PET) scan of the brain |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-01-31
- Last updated
- 2020-09-07
- Results posted
- 2020-09-07
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02051764. Inclusion in this directory is not an endorsement.